Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20230726058933N1Phase 3Completed
Phase 3, randomised, double-blind trial in shoulder pain comparing Tizanidine with Placebo (2 arms). Primary endpoints: Dose of painkillers received and Side effects of tizanidine. Started Sep 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20230726058933N1.